 |
|
||||||||||||
TessArae® is a next generation diagnostics company developing microarray-based tools and services for the simultaneous detection and definitive identification of hundreds of natural and emergent viral and bacterial pathogens, for medical and scientific research, and clinical diagnostics.
TessArae’s proprietary TessArray® Resequencing Pathogen Microarray (RPM)* technology enables numerous unique capabilities versus immunoassay and PCR, including:
TessArae’s proprietary TessArray® Resequencing Pathogen Microarray (RPM)* technology enables numerous unique capabilities versus immunoassay and PCR, including:
December 21, 2009
TessArae Receives Emergency Use Authorization from FDA for 2009 H1N1 Influenza Test